Logo image of SAN.PA

SANOFI (SAN.PA) Stock Overview

Europe - EPA:SAN - FR0000120578 - Common Stock

87.61 EUR
+1 (+1.15%)
Last: 10/24/2025, 10:52:19 AM

SAN.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap213.51B
Revenue(TTM)67.89B
Net Income(TTM)13.81B
Shares2.44B
Float2.18B
52 Week High110.88
52 Week Low76.15
Yearly Dividend3.79
Dividend Yield4.54%
EPS(TTM)7.55
PE11.6
Fwd PE10.1
Earnings (Next)10-24 2025-10-24/bmo
IPO2002-07-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


SAN.PA short term performance overview.The bars show the price performance of SAN.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

SAN.PA long term performance overview.The bars show the price performance of SAN.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -5 -10

The current stock price of SAN.PA is 87.61 EUR. In the past month the price increased by 11.73%. In the past year, price decreased by -13.46%.

SANOFI / SAN Daily stock chart

SAN.PA Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 50.8 669.81B
1LLY.MI ELI LILLY & CO 50 659.21B
ZEG.DE ASTRAZENECA PLC 18.82 444.61B
JNJ.DE JOHNSON & JOHNSON 18.49 398.58B
1JNJ.MI JOHNSON & JOHNSON 18.46 397.91B
RHO.DE ROCHE HOLDING AG-BR 14.36 247.14B
1ROG.MI ROCHE HOLDING AG-GENUSSCHEIN 13.92 239.54B
NOT.DE NOVARTIS AG-REG 14.99 218.87B
1NOVN.MI NOVARTIS AG-REG 14.99 218.75B
1SAN.MI SANOFI 11.45 210.73B
SNW.DE SANOFI 11.45 210.68B
NOV.DE NOVO NORDISK A/S-B 13.75 204.11B

About SAN.PA

Company Profile

SAN logo image Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Company Info

SANOFI

46 Avenue de la Grande Armee

Paris ILE-DE-FRANCE FR

Employees: 82878

SAN Company Website

SAN Investor Relations

Phone: 33153774000

SANOFI / SAN.PA FAQ

What is the stock price of SANOFI today?

The current stock price of SAN.PA is 87.61 EUR. The price increased by 1.15% in the last trading session.


What is the ticker symbol for SANOFI stock?

The exchange symbol of SANOFI is SAN and it is listed on the Euronext Paris - Matif exchange.


On which exchange is SAN.PA stock listed?

SAN.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for SANOFI stock?

29 analysts have analysed SAN.PA and the average price target is 109.66 EUR. This implies a price increase of 25.17% is expected in the next year compared to the current price of 87.61. Check the SANOFI stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SANOFI worth?

SANOFI (SAN.PA) has a market capitalization of 213.51B EUR. This makes SAN.PA a Mega Cap stock.


How many employees does SANOFI have?

SANOFI (SAN.PA) currently has 82878 employees.


What are the support and resistance levels for SANOFI (SAN.PA) stock?

SANOFI (SAN.PA) has a support level at 85.8 and a resistance level at 86.76. Check the full technical report for a detailed analysis of SAN.PA support and resistance levels.


Is SANOFI (SAN.PA) expected to grow?

The Revenue of SANOFI (SAN.PA) is expected to decline by -0.42% in the next year. Check the estimates tab for more information on the SAN.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SANOFI (SAN.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SANOFI (SAN.PA) stock pay dividends?

SANOFI (SAN.PA) has a dividend yield of 4.54%. The yearly dividend amount is currently 3.79. Check the full fundamental report for a detailed analysis of SAN.PA dividend history, reliability and sustainability.


When does SANOFI (SAN.PA) report earnings?

SANOFI (SAN.PA) will report earnings on 2025-10-24, before the market open.


What is the Price/Earnings (PE) ratio of SANOFI (SAN.PA)?

The PE ratio for SANOFI (SAN.PA) is 11.6. This is based on the reported non-GAAP earnings per share of 7.55 and the current share price of 87.61 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SAN.PA.


SAN.PA Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to SAN.PA. When comparing the yearly performance of all stocks, SAN.PA is a bad performer in the overall market: 85.39% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SAN.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA. While SAN.PA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SAN.PA Financial Highlights

Over the last trailing twelve months SAN.PA reported a non-GAAP Earnings per Share(EPS) of 7.55. The EPS decreased by -2.2% compared to the year before.


Industry RankSector Rank
PM (TTM) 20.35%
ROA 11.05%
ROE 19.73%
Debt/Equity 0.21
Chartmill High Growth Momentum
EPS Q2Q%-8.09%
Sales Q2Q%-6.99%
EPS 1Y (TTM)-2.2%
Revenue 1Y (TTM)6.45%

SAN.PA Forecast & Estimates

29 analysts have analysed SAN.PA and the average price target is 109.66 EUR. This implies a price increase of 25.17% is expected in the next year compared to the current price of 87.61.

For the next year, analysts expect an EPS growth of 4.12% and a revenue growth -0.42% for SAN.PA


Analysts
Analysts81.38
Price Target109.66 (25.17%)
EPS Next Y4.12%
Revenue Next Year-0.42%

SAN.PA Ownership

Ownership
Inst Owners47.5%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A